132 related articles for article (PubMed ID: 26964858)
1. Design of Highly Potent Lipid-Functionalized Peptidomimetics for Efficient in Vivo siRNA Delivery.
Xiao H; Altangerel A; Gerile G; Wu Y; Baigude H
ACS Appl Mater Interfaces; 2016 Mar; 8(12):7638-45. PubMed ID: 26964858
[TBL] [Abstract][Full Text] [Related]
2. PEGylation of 6-amino-6-deoxy-curdlan for efficient in vivo siRNA delivery.
Altangerel A; Cai J; Liu L; Wu Y; Baigude H; Han J
Carbohydr Polym; 2016 May; 141():92-8. PubMed ID: 26877000
[TBL] [Abstract][Full Text] [Related]
3. Delivery of siRNA Complexed with Palmitoylated α-Peptide/β-Peptoid Cell-Penetrating Peptidomimetics: Membrane Interaction and Structural Characterization of a Lipid-Based Nanocarrier System.
Jing X; Foged C; Martin-Bertelsen B; Yaghmur A; Knapp KM; Malmsten M; Franzyk H; Nielsen HM
Mol Pharm; 2016 Jun; 13(6):1739-49. PubMed ID: 26654841
[TBL] [Abstract][Full Text] [Related]
4. Design of Peptidomimetic Functionalized Cholesterol Based Lipid Nanoparticles for Efficient Delivery of Therapeutic Nucleic Acids.
Ehexige E; Ganbold T; Yu X; Han S; Baigude H
Molecules; 2019 Sep; 24(18):. PubMed ID: 31546908
[TBL] [Abstract][Full Text] [Related]
5. Surface coating of siRNA-peptidomimetic nano-self-assemblies with anionic lipid bilayers: enhanced gene silencing and reduced adverse effects in vitro.
Zeng X; de Groot AM; Sijts AJ; Broere F; Oude Blenke E; Colombo S; van Eden W; Franzyk H; Nielsen HM; Foged C
Nanoscale; 2015 Dec; 7(46):19687-98. PubMed ID: 26553270
[TBL] [Abstract][Full Text] [Related]
6. N-acetylgalactosamine functionalized mixed micellar nanoparticles for targeted delivery of siRNA to liver.
Wang HX; Xiong MH; Wang YC; Zhu J; Wang J
J Control Release; 2013 Mar; 166(2):106-14. PubMed ID: 23266452
[TBL] [Abstract][Full Text] [Related]
7. A peptidomimetic siRNA transfection reagent for highly effective gene silencing.
Utku Y; Dehan E; Ouerfelli O; Piano F; Zuckermann RN; Pagano M; Kirshenbaum K
Mol Biosyst; 2006 Jun; 2(6-7):312-7. PubMed ID: 16880950
[TBL] [Abstract][Full Text] [Related]
8. Lipidic carriers of siRNA: differences in the formulation, cellular uptake, and delivery with plasmid DNA.
Spagnou S; Miller AD; Keller M
Biochemistry; 2004 Oct; 43(42):13348-56. PubMed ID: 15491141
[TBL] [Abstract][Full Text] [Related]
9. Silencing of STAT3 via Peptidomimetic LNP-Mediated Systemic Delivery of RNAi Downregulates PD-L1 and Inhibits Melanoma Growth.
Ehexige E; Bao M; Bazarjav P; Yu X; Xiao H; Han S; Baigude H
Biomolecules; 2020 Feb; 10(2):. PubMed ID: 32059541
[TBL] [Abstract][Full Text] [Related]
10. RNAi-mediated gene silencing in non-human primates.
Zimmermann TS; Lee AC; Akinc A; Bramlage B; Bumcrot D; Fedoruk MN; Harborth J; Heyes JA; Jeffs LB; John M; Judge AD; Lam K; McClintock K; Nechev LV; Palmer LR; Racie T; Röhl I; Seiffert S; Shanmugam S; Sood V; Soutschek J; Toudjarska I; Wheat AJ; Yaworski E; Zedalis W; Koteliansky V; Manoharan M; Vornlocher HP; MacLachlan I
Nature; 2006 May; 441(7089):111-4. PubMed ID: 16565705
[TBL] [Abstract][Full Text] [Related]
11. Design and creation of new nanomaterials for therapeutic RNAi.
Baigude H; McCarroll J; Yang CS; Swain PM; Rana TM
ACS Chem Biol; 2007 Apr; 2(4):237-41. PubMed ID: 17432823
[TBL] [Abstract][Full Text] [Related]
12. Sequential intravenous injection of anionic polymer and cationic lipoplex of siRNA could effectively deliver siRNA to the liver.
Hattori Y; Arai S; Okamoto R; Hamada M; Kawano K; Yonemochi E
Int J Pharm; 2014 Dec; 476(1-2):289-98. PubMed ID: 25290812
[TBL] [Abstract][Full Text] [Related]
13. RNAi-mediated suppression of constitutive pulmonary gene expression by small interfering RNA in mice.
Gutbier B; Kube SM; Reppe K; Santel A; Lange C; Kaufmann J; Suttorp N; Witzenrath M
Pulm Pharmacol Ther; 2010 Aug; 23(4):334-44. PubMed ID: 20362688
[TBL] [Abstract][Full Text] [Related]
14. Development of lipid nanoparticle formulations of siRNA for hepatocyte gene silencing following subcutaneous administration.
Chen S; Tam YY; Lin PJ; Leung AK; Tam YK; Cullis PR
J Control Release; 2014 Dec; 196():106-12. PubMed ID: 25285610
[TBL] [Abstract][Full Text] [Related]
15. Strategies for in vivo delivery of siRNAs: recent progress.
Higuchi Y; Kawakami S; Hashida M
BioDrugs; 2010 Jun; 24(3):195-205. PubMed ID: 20462284
[TBL] [Abstract][Full Text] [Related]
16. Efficient intracellular delivery and multiple-target gene silencing triggered by tripodal RNA based nanoparticles: a promising approach in liver-specific RNAi delivery.
Sajeesh S; Lee TY; Kim JK; Son DS; Hong SW; Kim S; Yun WS; Kim S; Chang C; Li C; Lee DK
J Control Release; 2014 Dec; 196():28-36. PubMed ID: 25251899
[TBL] [Abstract][Full Text] [Related]
17. Small interfering RNA delivery to the liver by intravenous administration of galactosylated cationic liposomes in mice.
Sato A; Takagi M; Shimamoto A; Kawakami S; Hashida M
Biomaterials; 2007 Mar; 28(7):1434-42. PubMed ID: 17141864
[TBL] [Abstract][Full Text] [Related]
18. Influence of particle size on the in vivo potency of lipid nanoparticle formulations of siRNA.
Chen S; Tam YYC; Lin PJC; Sung MMH; Tam YK; Cullis PR
J Control Release; 2016 Aug; 235():236-244. PubMed ID: 27238441
[TBL] [Abstract][Full Text] [Related]
19. Efficient in vivo delivery of siRNA to the liver by conjugation of alpha-tocopherol.
Nishina K; Unno T; Uno Y; Kubodera T; Kanouchi T; Mizusawa H; Yokota T
Mol Ther; 2008 Apr; 16(4):734-40. PubMed ID: 18362929
[TBL] [Abstract][Full Text] [Related]
20. A biomimetic nanovector-mediated targeted cholesterol-conjugated siRNA delivery for tumor gene therapy.
Ding Y; Wang W; Feng M; Wang Y; Zhou J; Ding X; Zhou X; Liu C; Wang R; Zhang Q
Biomaterials; 2012 Dec; 33(34):8893-905. PubMed ID: 22979990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
